GlassScriptPhysician profile
Todd Edward Lininger
NPI 1386623502
$10,573.85
in general payments reported to CMS, 2019-2025
46 companies · $1,321 in 2025
The $1,321 reported for 2025 was more than what a typical Pain Medicine provider received nationally (typical 2025 total: $515).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,183 · 2020: $943 · 2021: $1,247 · 2022: $2,404 · 2023: $1,519 · 2024: $958 · 2025: $1,321.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,798.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,797.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $3,441.61 | 2019-2024 | Senza |
| Medtronic, INC. | $981.57 | 2021-2025 | Intellis Adaptivestim, Synchromedii, Inceptiv |
| Boston Scientific Corporation | $774.86 | 2019-2021 | |
| Globus Medical, INC. | $762.88 | 2025 | Senza |
| Medtronic USA, INC. | $671.63 | 2019-2020 | |
| Abbott Laboratories | $522.30 | 2019-2025 | Proclaim, Eterna |
| Abbvie INC. | $415.86 | 2022-2025 | |
| Collegium Pharmaceutical, INC. | $340.41 | 2019-2024 | Xtampza |
| Nalu Medical, INC. | $273.66 | 2022-2025 | Nalu Neurostimulation System |
| Allergan, INC. | $236.38 | 2019-2022 | |
| Curonix LLC | $206.10 | 2023-2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Saluda Medical Americas, INC. | $197.30 | 2023-2025 | Evoke, Evoke Scs |
| Tersera Therapeutics LLC | $152.11 | 2019-2024 | Prialt |
| Vertos Medical, INC. | $147.00 | 2019 | |
| Amgen INC. | $134.93 | 2019-2021 |
Show all 46 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Todd Lininger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.